Aromatic Molecular Compatibility Attenuates Influenza Virus-Induced Acute Lung Injury via the Lung–Gut Axis and Lipid Droplet Modulation
Open Access
- 26 March 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (4) , 468
Abstract
Background: Acute lung injury (ALI) is a major cause of death in patients with various viral pneumonias. Our team previously identified four volatile compounds from aromatic Chinese medicines. Based on molecular compatibility theory, we defined their combination as aromatic molecular compatibility (AC), though its therapeutic effects and underlying mechanisms remain unclear. Methods: This study used influenza A virus (IAV) A/PR/8/34 to construct cell and mouse models of ALI to explore AC’s protective effects against viral infection. The therapeutic effect of AC was verified by evaluating the antiviral efficacy in the mouse models, including improvements in their lung and colon inflammation, oxidative stress, and the suppression of the NLRP3 inflammasome. In addition, 16S rDNA and lipid metabolomics were used to analyze the potential therapeutic mechanisms of AC. Results: Our in vitro and in vivo studies demonstrated that AC increased the survival of the IAV-infected cells and mice, inhibited influenza virus replication and the expression of proinflammatory factors in the lung tissues, and ameliorated barrier damage in the colonic tissues. In addition, AC inhibited the expression of ROS and the NLRP3 inflammasome and improved the inflammatory cell infiltration into the lung tissues. Finally, AC effectively regulated intestinal flora disorders and lipid metabolism in the model mice, significantly reduced cholesterol and triglyceride expression, and thus reduced the abnormal accumulation of lipid droplets (LDs) after IAV infection. Conclusions: In this study, we demonstrated that AC could treat IAV-induced ALIs through multiple pathways, including antiviral and anti-inflammatory pathways and modulation of the intestinal flora and the accumulation of LDs.Keywords
Funding Information
- National Natural Science Foundation of China (82141217)
This publication has 48 references indexed in Scilit:
- Regulation of NLRPs by reactive oxygen species: A story of crosstalkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2024
- T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infectionsCell Reports, 2023
- Anti-inflammatory mechanisms of eucalyptol rich Eucalyptus globulus essential oil alone and in combination with flurbiprofenInflammopharmacology, 2023
- TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicityCell, 2021
- Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiotaBiomedicine & Pharmacotherapy, 2021
- Coinfection in SARS‐CoV‐2 infected patients: Where are influenza virus and rhinovirus/enterovirus?Journal of Medical Virology, 2020
- The cytokine storm and COVID‐19Journal of Medical Virology, 2020
- The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreakJournal of Medical Virology, 2020
- Viral Generated Inter-Organelle Contacts Redirect Lipid Flux for Genome ReplicationCell, 2019
- Quantitative Lipid Droplet Proteome Analysis Identifies Annexin A3 as a Cofactor for HCV Particle ProductionCell Reports, 2016